Twist Bioscience Corporation
Income Statement
| Line Item | FY2017 |
|---|---|
| Revenue | $10.8M |
| Cost of Revenue | $24.0M |
| Gross Profit | $-13.3M |
| Gross Margin | -123.1% |
| Operating Expenses | |
| Research & Development | $19.2M |
| SG&A Expense | $26.1M |
| Operating Income | $-58.5M |
| Operating Margin | -543.2% |
| Interest Expense | $905.0K |
| Pretax Income | $-59.0M |
| Income Tax Expense | $280.0K |
| Net Income | $-59.3M |
| Net Margin | -550.8% |
| EPS (Basic) | $-24.49 |
| EPS (Diluted) | $-24.49 |
| Shares Outstanding (Basic) | — |
| Shares Outstanding (Diluted) | — |
| Dividends Per Share | — |